FDAnews Device Daily Bulletin

GLOBAL ANALYSIS OF DIABETES PRODUCTS, TECHNOLOGIES AND MARKETS REVEALS MANY OPPORTUNITIES FOR DEVICE, DRUG AND DIAGNOSTICS MANUFACTURERS

Dec. 19, 2005
A A

The global diabetes market is an aggregate of drugs/medications, devices, diagnostics, therapeutics and their combinations. Medications segment into insulins and orally-taken drugs; the insulin market now consists almost entirely of human insulins. The orally active drugs segment is comprised of multiple drug classes, with older categories losing market share to newcomers, and while the diabetes medication market has previously been slow to adopt new formulations, this is rapidly changing.

PRWeb (http://www.prweb.com/printer.php?prid=322112)